Track Orion Biotech Opportunities - Units (1 Ord Share Class A & 1/5 War)'s net tangible assets ($200M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (December 2022), ORIAU shows a net tangible assets of $200M. That compares with $-14M in the prior-year period — up 1517.6% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, ORIAU's net tangible assets is now $200M (was $-14M) — a 1517.6% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Orion Biotech Opportunities - Units (1 Ord Share Class A & 1/5 War) is outperforming or lagging.
Tracking ORIAU's net tangible assets over time shows whether Orion Biotech Opportunities - Units (1 Ord Share Class A & 1/5 War) is scaling, shrinking, or reshaping that part of the business. The current reading is $200M That compares with $-14M in the prior-year period — up 1517.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this net tangible assets page, Stockcircle has Orion Biotech Opportunities - Units (1 Ord Share Class A & 1/5 War)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect net tangible assets (currently $200M) with ownership activity and broader fundamentals.